 Connection
Petter Bjornstad to Blood Glucose
This is a "connection" page, showing publications Petter Bjornstad has written about Blood Glucose.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.233 |
|
|
|
-
Bjornstad P, McQueen RB, Snell-Bergeon JK, Cherney D, Pyle L, Perkins B, Rewers M, Maahs DM. Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes? PLoS One. 2014; 9(4):e96264.
Score: 0.200
-
Pinzon Cortes JA, Narongkiatikhun P, Snethlage CF, Del Castillo D, Tommerdahl KL, Nadeau KJ, Bjornstad P. Beyond Glycemia in T1D: Insulin Resistance and Multiorgan Injury in Type 1 Diabetes-Part 2. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):407-419.
Score: 0.115
-
Pinzon Cortes JA, Narongkiatikhun P, Fuhri Snethlage CM, Del Castillo D, Tommerdahl KL, Nadeau KJ, Bjornstad P. Beyond Glycemia in T1D: The Hidden Burden of Insulin Resistance and Cardiorenal Risk in Type 1 Diabetes-Part 1. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):395-405.
Score: 0.115
-
Dobbs TJ, Pyle L, Moore JM, Garrish J, Behn CD, Weissenkampen D, Baumgartner AD, Gross S, Schutte G, Birznieks C, Melena I, Remmers L, Driscoll L, Cree MG, Kelsey MM, Shah AS, Inge TH, Bjornstad P, Nadeau KJ. Impact of Vertical Sleeve Gastrectomy in Youth-Onset Type 2 Diabetes: Changes in Glycemia, Insulin Sensitivity, and Secretion. Obesity (Silver Spring). 2026 Jun; 34 Suppl 1:121-133.
Score: 0.113
-
Simonsen JR, Gordin D, Januszewski AS, Jenkins AJ, van Raalte DH, van Baar MJ, Bjornstad P, Thorn LM, Groop PH. A pilot study on measured insulin sensitivity and estimated glucose disposal rates in adults with type 1 diabetes and diabetic kidney disease. Endocrine. 2026 02 03; 91(1):61.
Score: 0.113
-
Bjornstad P, Hughan K, Kelsey MM, Shah AS, Lynch J, Nehus E, Mitsnefes M, Jenkins T, Xu P, Xie C, Inge T, Nadeau K. Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes. Diabetes Care. 2020 01; 43(1):187-195.
Score: 0.073
-
Vigers T, Chan CL, Snell-Bergeon J, Bjornstad P, Zeitler PS, Forlenza G, Pyle L. cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data. PLoS One. 2019; 14(10):e0216851.
Score: 0.073
-
Scholtes RA, van Baar MJB, Lytvyn Y, Bjornstad P, Nieuwdorp M, Cherney DZI, van Raalte DH. Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes Obes Metab. 2019 04; 21 Suppl 2:24-33.
Score: 0.070
-
León Jiménez D, Cherney DZI, Bjornstad P, Castilla-Guerra L, Miramontes González JP. Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1406-F1415.
Score: 0.067
-
Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
Score: 0.064
-
Bjornstad P, Lanaspa MA, Ishimoto T, Kosugi T, Kume S, Jalal D, Maahs DM, Snell-Bergeon JK, Johnson RJ, Nakagawa T. Fructose and uric acid in diabetic nephropathy. Diabetologia. 2015 Sep; 58(9):1993-2002.
Score: 0.054
-
Bjornstad P, Cree-Green M, Baumgartner A, Maahs DM, Cherney DZ, Pyle L, Regensteiner JG, Reusch JE, Nadeau KJ. Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes. Diabetes Care. 2015 Jan; 38(1):126-31.
Score: 0.052
-
Mahmud FH, Bjornstad P, Clarson C, Clarke A, Anthony SJ, Curtis J, Elia YT, McArthur L, Mertens L, Moineddin R, Kirsch S, Coles N, Maione M, Furman M, Babalola F, Tommerdahl KL, Harrington J, Riddell MC, Prasad P, Huang L, Heerspink HJL, Cherney DZI. Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Nat Med. 2025 Jul; 31(7):2317-2324.
Score: 0.027
-
van Baar MJB, Muskiet MHA, Scholtes RA, Touw DJ, Nieuwdorp M, Kramer MHH, Joles JA, Cherney DZI, Bjornstad P, Krebber MM, van Raalte DH. Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial. Diabetes Obes Metab. 2025 07; 27(7):3943-3956.
Score: 0.027
-
Goswami S, Gist KM, Bjornstad P, Ciccia E, Deep A, Gelbart B, Menon S, Marinari E, Ollberding NJ, Qutob D, Seo J, Soranno DE, Van Wyk B, Starr MC. Hyperglycemia and kidney outcomes in critically ill children and young adults on continuous kidney replacement therapy. Pediatr Nephrol. 2025 Sep; 40(9):2957-2966.
Score: 0.027
-
Chen ZZ, Lu C, Dreyfuss JM, Tiwari G, Shi X, Zheng S, Wolfs D, Pyle L, Bjornstad P, El Ghormli L, Gerszten RE, Isganaitis E. Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes. Diabetes Care. 2024 09 01; 47(9):1597-1607.
Score: 0.026
-
Al-Ozairi E, Rivard CJ, Sanchez Lozada LG, Lanaspa MA, Bjornstad P, Al Salem D, Alhubail A, Megahed A, Kuwabara M, Johnson RJ, Asad RA. Fructose tolerance test in obese people with and without type 2 diabetes. J Diabetes. 2020 Mar; 12(3):197-204.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|